![]() |
Choi Jun-Gui (left), president of the Catholic University of Korea, and COSMAX Group Chairman Kyung-Soo Lee pose for a photo at a memorandum of understanding (MOU) signing ceremony held at the university's Songeui Campus in Seocho District, Seoul, in June. /Cosmax
Cosmetics original development manufacturing (ODM) company COSMAX has partnered with Lee Ji-hyun, a dermatology professor at the Catholic University of Korea's Seoul St. Mary's Hospital, to establish a medical skincare joint venture (JV). The MOU on industry-academia cooperation signed with the university in June has led to the establishment of a new company. The initiative aims to explore new business opportunities by combining the university hospital's dermatological research capabilities with cosmetics manufacturing technology.
According to the Financial Supervisory Service's Data Analysis, Retrieval and Transfer System (DART) on Nov. 17, COSMAX established Celestial Medi Skincare Co., Ltd. at the end of September and added it as a subsidiary. COSMAX holds a 51% stake in the company, with a capital contribution of 51 million won. The company is based at Omnibus Park on the Catholic University of Korea's Songeui Campus in Seocho District, Seoul.
The joint venture marks the first tangible outcome of the MOU signed on June 8 by COSMAX Group Chairman Lee Kyung-soo and Catholic University of Korea President Choi Jun-gui. At the time, COSMAX pledged to provide 1 billion won in research funding and 150 million won in scholarships over the next five years. It also agreed to pursue the commercialization of medical technologies in collaboration with the university's Industry-Academic Cooperation Foundation.
The joint venture will pursue projects that incorporate medical technology into cosmetics research and development (R&D). Its focus will be on commercializing technologies based on the university hospital's dermatological research findings rather than operating its own brand.
Lee Ji-hyun, a dermatology professor at Seoul St. Mary's Hospital, participated in establishing the company as a faculty entrepreneur. Lee is a specialist in skin immunology who studied biological sciences at KAIST and medicine at the Catholic University of Korea. Lee previously served as director of planning at the Korean Atopic Dermatitis Association, among other positions, and has conducted research on atopic dermatitis, psoriasis and other conditions. Lee also previously received an award from the Minister of Trade, Industry and Energy for developing dermatological medical devices.
COSMAX has lent the newly established company 900 million won in operating funds. As of the end of the third quarter, Celestial Medi Skincare had total assets of 1,056.91 million won and revenue of 6.31 million won. Given that the company is still in its early stages, it is focusing on establishing its R&D foundation and operational framework rather than generating substantial business results.
The company has also begun recruiting personnel for its business operations. On Oct. 7, job postings were published for a head of operations and a business operations specialist at Celestial Medi Skincare. The company sought candidates with 15 to 25 years of experience for the head of operations position and three to 10 years of experience for the business operations position.
"As an extension of the MOU signed with the Catholic University of Korea in June, we established the JV to commercialize technologies that combine medical and cosmetics technologies," a COSMAX official said. "As the company is still in its early stages, we are currently exploring potential research topics." The official added, "With biotechnology being actively incorporated across the cosmetics industry, related research and development will get underway in earnest."
Kang Hye-won |
1
2
3
4
5
6
7